Myometrial and stromal lesions of the uterus.
This article is an overview of uterine neoplasms that demonstrate mesenchymal differentiation. Major clinical and pathologic features are described, with a focus on those lesions that cause diagnostic difficulty. Brief discussions on more recent observations made concerning these entities are also included.
Smoot
J S
JS
Department of Pathology, University of California, San Francisco, USA.
Zaloudek
C
C
D000232:Adenofibroma / Q000473:pathology; D018194:Adenomyoma / Q000473:pathology; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D016889:Endometrial Neoplasms / Q000145:classification / Q000473:pathology; D005260:Female; D006801:Humans; D018231:Leiomyomatosis / Q000473:pathology; D016729:Leuprolide / Q000627:therapeutic use; D009215:Myometrium / Q000473:pathology*; D011956:Receptors, Cell Surface / Q000032:analysis; D012509:Sarcoma / Q000473:pathology; D017154:Stromal Cells / Q000473:pathology; D014594:Uterine Neoplasms / Q000145:classification / Q000473:pathology*; D014599:Uterus / Q000473:pathology*
D018931:Antineoplastic Agents, Hormonal; D011956:Receptors, Cell Surface; D016729:Leuprolide